# Muscle Impact of Treating Osteoporosis

> **NCT05666310** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Nami Safai Haeri** · enrollment: 20 (actual)

## Conditions studied

- Sarcopenia
- Osteoporosis

## Interventions

- **DRUG:** Denosumab
- **DRUG:** Zoledronic Acid
- **OTHER:** Denosumab Placebo
- **OTHER:** Zoledronic Acid Placebo

## Key facts

- **NCT ID:** NCT05666310
- **Lead sponsor:** Nami Safai Haeri
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-02-14
- **Primary completion:** 2026-01-05
- **Final completion:** 2026-09-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-01-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05666310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05666310, "Muscle Impact of Treating Osteoporosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05666310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*